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A B S T R A C T
Background: To date, no hospital-based national study with large sample size has been 
conducted to determine the predictive factors of in-hospital mortality among patients 
with Myocardial Infarction (MI) in Iran.
Objectives: This study aimed to determine in-hospital Case Fatality Rate (CFR) and hazard 
ratio of the factors associated with mortality in the patients with MI diagnosis in Iran.
Patients and Methods: In this nationwide, hospital-based, prospective study, 
the researchers made use of the data of 20750 new MI cases registered by Iranian 
Myocardial Infarction Registry (IMIR) in 31 provinces between April 2012 and March 
2013. Demographic, clinical, and laboratory variables were obtained from the medical 
records of patients with confirmed acute MI. Cox regression was done by Stata software, 
version 12 using univariate and multiple analyses through Breslow method. P < 0.05 was 
considered as statistically significant.
Results: In-hospital mortality rate was 12.1% (N = 2511) and female/male ratio of CFR 
was 1.36 (95% CI: 1.2 - 1.4). Besides, in-hospital CFR was 8.36: 7.81 - 8.94 in females and 
6.12: 5.83 - 6.43 in males. Hazard ratio of mortality for ST segment Elevation Myocardial 
Infarction (STEMI), chest pain resistant to treatment, and Right Bundle Branch Block 
(RBBB) was 1.32, 4.06, and 2.45, respectively (P < 0.01). Using Percutaneous Coronary 
Intervention (PCI) decreased the risk of death in the patients (HR: 0.68). Overall, 83.7% 
of the patients with STEMI died.
Conclusions: In Iran, identifying the risk factors of mortality due to MI could contribute 
to detecting high-risk individuals and improving healthcare by relevant planning and 
interventions in clinics and communities.
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Shahrekord, Iran. Tel: +98-3813330065, 
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1. Background
Despite decrease in mortalities due to Myocardial 
Infarction (MI) in many countries, this disease is the leading 
cause of mortality in developing countries, including Iran 
(1, 2). MI is the most important and prevalent coronary 
heart disease. Coronary heart disease is the reason for one 
per six deaths in the United States (3). According to the 
report by Iran’s Ministry of Health, Treatment, and Medical 
Education in 2011, the mortality rate due to MI was 103 
per 100000 deaths (4). Additionally, mortality rate due to 
►Implication for health policy/practice/research/medical education:
The findings of the present study could be conducive to planning in health systems as well as to monitoring and improving patients’ care and 
treatment.
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MI prior to arriving at hospitals is high and is estimated 
to be approximately 20% in Iran. In-hospital mortality 
rate due to MI varies between 7.7% and 19.2% worldwide. 
One-year mortality rate due to MI also varies from 23% 
to 25.3% (5, 6). Coronary heart disease is a multifactorial 
disorder for which more than 250 risk factors have been 
introduced so far (7-9). Aging, male gender, hypertension, 
diabetes, smoking, and dyslipidemia are considered as 
important risk factors for MI. Furthermore, in-hospital 
mortality rate is higher among women compared to men. 
Yet, controversial results have been obtained regarding the 
above-mentioned factors (10, 11). Identifying the predictive 
factors of mortality contributes greatly to decreasing the 
mortality rate in patients. Up to now, no hospital-based, 
national study with large sample size has been conducted 
to determine the predictive factors of in-hospital mortality 
in the patients with MI in Iran.
2. Objectives
This study aims to determine in-hospital Case Fatality 
Rate (CFR) and hazard ratio of the factors associated with 
mortality in the patients with MI diagnosis in Iran.
3. Patients and Methods
In this nationwide, hospital-based, prospective study, the 
researchers made use of the data of 20750 new MI cases 
registered by Iranian Myocardial Infarction Registry (IMIR) 
in 31 provinces between April 2012 and March 2013. IMIR 
collects the data from Cardiac Care Units (CCUs) of all the 
hospitals across the country (12). This study was approved 
by the Ethics Committee of Shahid Beheshti University 
of Medical Sciences. MI diagnosis was based on the 
definitions provided by World Health Organization (WHO), 
World Heart Federation, and International Classification of 
Diseases (codes I21, I22, I24.9, and I25) (13). The patients 
with no definite diagnosis of MI by a cardiologist were 
excluded from the study. The underlying and predictive 
data were gathered for demographic variables, such as age, 
gender, province of residence, and length of hospital stay, as 
well as the, risk factors and clinical and laboratory history, 
including type 2 diabetes, hypertension, smoking, history 
of heart disease, Coronary Artery Bypass Surgery Graft 
surgery (CABG), Percutaneous Coronary Intervention 
(PCI), dyslipidemia, ischemic pain pattern, place of 
MI, cardiac blocks, complications of MI, ventricular 
arrhythmias, and troponin. In-hospital mortality due to 
MI was set as the dependent variable. Duration of exposure 
to risk of in-hospital mortality was calculated using the 
date of hospitalization and the date of discharge or death. 
The variables with P < 0.2 were entered into multiple Cox 
regression model using univariate analysis through Breslow 
method. Then, the presuppositions were investigated and 
confirmed by Schoenfeld residuals (Phtest). All data 
analyses were performed using Stata software (Stata Corp. 
2011. Stata Statistical Software: Release 12. College Station, 
TX: Stata Corp LP).
4. Results
In this study, follow-up was from definite diagnosis of 
MI to death. The prospective cohort of the patients was 
defined in view of the date of diagnosis, hospitalization, and 
discharge (recovery or in-hospital death due to MI). Overall, 
20750 patients with MI at risk of in-hospital death with 
total hospitalization of 3724983 person-years were studied. 
Among these patients, 15033 (72.4%) were male and the rest 
were female. Mean age at MI incidence was significantly 
lower in males than in females (P = 0.001). Demographic 
variables and clinical risk factors of the deceased and 
survived patients have been presented in Tables 1 and 2. 
Accordingly, hypertension and diabetes were significantly 
more prevalent in the deceased patients compared to the 
survived ones. Besides, 83.7% of the patients with ST 
segment Elevation Myocardial Infarction (STEMI) died. 
The frequency of PCI use was higher in the survived 
patients than in the deceased ones. Furthermore, 37.15% 
of the survived patients and only 7.29% of the deceased 
ones had used thrombolytic therapy. In-hospital mortality 
rate was 12.1% (N = 2511). In addition, in-hospital fatality 
rate was 6.74 (95% CI: 6.48 - 7); 6.12 (95% CI: 5.83 - 6.43) 
in males and 8.36 (95% CI: 7.81 - 8.94) in females. Besides, 
female/male ratio of fatality was 1.36 (95% CI: 1.2 - 1.4). 
In-hospital fatality rate due to MI based on age and gender 
Table 1. Demographic Characteristics and Medical History of the Study Population
Characteristics Total Survived Deceased P value
Age (year) a 61.2 ± 13.4 60.65 ± 13 65.2 ± 15.2 0.001
Hospital stay (day) a 6.5 ± 14.6 6.57 ± 14.6 6.43 ± 14.4 0.647
Gender b
Male
15033 13377 1656
0.001
72.4% 64.6% 7.9%
Female
5717 4862 855
0.001
27.6% 23.4% 4.12%
Smoker b
5443 4667 776
0.001
26.2% 25.6% 30.9%
Hypertension b
7376 6426 950
0.011
35.5% 35.2% 37.8%
Diabetes mellitus b
4612 22.2% 4002
0.008
21.9% 610 24.3%
Hyperlipidemia b
3710 3268 442
0.699
17.8% 17.9% 17.6%
a Mean ± SD, b Frequency and percentage
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has been shown in Table 3.
In univariate analysis, age, gender, education level, 
smoking, hypertension, type 2 diabetes, PCI, chest pain, 
heart failure, heart rupture, troponin, and laterality of MI 
were yielded as significant (P < 0.03) and were entered 
into the Cox regression model. The final model of death 
determinants in the patients has been presented in Table 
4. In univariate analysis, the hazard ratio was 3.27 for 
STEMI. In multivariate analysis, however, the hazard ratio 
decreased to 2.88 in presence of other variables and after 
controlling the confounding variables.
5. Discussion
The present study was done based on the registered 
data of MI patients in Iran. This was the first national 
study investigating the predictive risk factors of in-
hospital mortality in Iran. Based on the study findings, 
the most important risk factors of in-hospital mortality 
due to MI were age, female gender, education level, type 
2 diabetes, smoking, PCI, Right Bundle Branch Block 
(RBBB), STEMI, Ventricular Tachycardia (VT), and 
lack of thrombolytic therapy. Up to now, no study has 
comprehensively examined the predictive factors of short-
term survival after MI in Iran. Thus, it could be argued that 
this study is the first one in this field with a large sample 
size, based on the population of all provinces of Iran, and 
with definite diagnosis of MI based on WHO’s criteria. 
The results of the present study showed that 72.4% of the 
patients were male and the rest were female, and male/
female ratio was 2.69. In a study in France, 23.5% of the 
patients with MI were female and 76.5% were male. In 
that study, the patients’ mean age was 62.6 years, which is 
similar to our study, and mortality rate was 9% in females 
and more than 4% in males. In addition, age at MI incidence 
was 8 years earlier in males, while the risk factors were 
more prevalent in females (14). In a study by Uchiyama 
in Japan, 78.5% of the patients were male (15), which is 
relatively similar to the gender ratio in our study.
According to the current study findings, men developed 
Table 2. Clinical Characteristics of the Study Population
Characteristics Total Survived Deceased P value
VF
511 371 140
0.001
2.5% 2% 5.5%
VT
1198 934 264
0.001
5.8% 5.1% 10.5%
Lateral MI
990 817 173
0.001
4.8% 3.94% 0.83%
Anterior MI
4332 3765 567
0.025
20.9% 18.14% 2.73%
Inferior MI
7179 6354 825
0.05
34.6% 30.62% 3.98%
Posterior MI
853 744 109
0.536
4.2% 3.59% 0.53%
STEMI
15729 13626 2103
0.001
75.8% 16.2% 83.7%
Non-STEMI
5021 4613 408
0.001
24.2% 25.2% 16.2%
PCI
1431 1354 77
0.001
6.9% 7.4% 3.07%
CABG
539 469 70
0.523
2.6% 2.5% 2.8%
Lack of thrombolytic therapy
9222 7709 1513
0.001
44.5% 37.15% 7.29%
Chest pain
2229 1356 873
0.001
10.7% 6.53% 4.21%
Abbreviations: VF, ventricular fibrillation; VT, ventricular tachycardia; MI, myocardial infarction; STEMI, ST-segment elevation 
myocardial infarction; NSTEMI, non ST-segment elevation myocardial infarction; PCI, percutaneous Coronary Intervention; CABG, 
coronary artery bypass grafting
Table 3. In-Hospital Mortality Rate with 95% Confidence Interval and Case Fatality Rate due to MI in Iran’s Hospitals
Gender Age Group Number MI (CFR %) IMR a: 95% CI
Female
< 65 years 2690(47) 6.49 : 5.79 - 7.28
≥ 65 years 3027(53) 9.84 : 9.05 - 10.68
Total females 5717(27.6) 8.36 : 7.81 – 8.94
Males
< 65 years 9814(65.3) 5.3 : 4.96 - 5.65
≥ 65 years 5219(34.7) 7.5 : 7.02 – 8.1
Total males 15033(72.4) 6.12: 5.83 - 6.43
Total 2511(12.1) 6.74: 6.48 - 7
a in 100 person years
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MI about 5.2 years earlier compared to women, which is 
in line with the results of some other studies conducted 
on the issue. However, mean age at in-hospital death was 
lower in our study than in Uchiyama’s study. In that study, 
mean age at MI incidence was 67.9 years and mean age at 
death was 76.1 years (15).
In our study, the risk of in-hospital death due to MI was 
1.2 times higher in women than in men, which is consistent 
with other studies. For instance, Randall reported that the 
risk of mortality was higher in women compared to men. In 
another study in Norway, mortality rate increased with age 
and in-hospital mortality rate was reported as 3.8%. Besides, 
mortality rate was higher in women (19%) than in men 
(13.9%) (16-18). In-hospital mortality and post-MI survival 
are highly associated with the disease severity. In addition, 
quality of healthcare and the type of treatments used by 
the patients contribute greatly to the patients’ survival. 
The positive effects of thrombolytic drugs and PCI have 
been reported by different studies (19, 20). In the present 
study, the patients with no thrombolytic therapy were at a 
higher risk of death in comparison to those receiving PCI. 
Nevertheless, the frequency of PCI use seems to be lower 
in Iran compared to other countries. Infrequent use of this 
treatment and lower administration of thrombolytic drugs 
seem to explain the higher mortality rate in Iran. Smoking 
was another predictive factor of death in the patients in our 
study, which is consistent with the results of other studies. 
In addition, type of MI was an important determinant of 
death, which is in agreement with the previous researches 
conducted in this regard. In several studies, an association 
was reported between smoking and mortality due to MI. One 
study indicated that smoking decreased the risk of death in 
the patients (HR: 0.85; 95% CI: 0.76-0.95; P = 0.005). In 
that study, mortality rate was 5.4% in smokers and 9.9% in 
non-smokers. Besides, smoking was associated with a 48% 
decrease in the risk of mortality for all reasons within one 
year after acute MI (20). Our study was not consistent with 
the aforementioned one and showed that smoking increased 
the risk of death in the patients. On the other hand, it was 
in line with a study in Turkey reporting that smoking and 
diabetes increased the risk of death in the patients (21). Our 
study was also in agreement with a study in India reporting 
gender, ventricular fibrillation, and heart failure as mortality-
associated factors in the patients and diabetes, hypertension, 
and smoking as the main risk factors in the patients with MI 
(22). Moreover, another study demonstrated that the used 
treatments, including CABG and PCI, decreased mortality 
in the patients with MI. In the study in India, 52.3%, 15.3%, 
and 7.5% of the patients used thrombolytic therapy, PCI, and 
CABG, respectively. Nonetheless, these treatments are used 
less frequently in Iran. Other studies also indicated that the 
rate of mortality was higher in the patients not receiving the 
above-mentioned treatments.
In the present study, illiteracy was another risk factor 
of death in the patients, which is in agreement with other 
works (22-24).
5.1. Conclusion
Our study reported in-hospital fatality rate with hazard 
ratios in the patients with MI across Iran. The results 
indicated that female gender, smoking, low education 
level, illiteracy, type 2 diabetes, VT, STEMI, RBBB, 
lack of thrombolytic therapy and angioplasty (PCI), and 
chest pain resistant to treatment were the most important 
determinants of death due to MI in Iran. The findings of the 
present study could be conducive to planning in the health 
system as well as to monitoring and improving patients’ 
care and treatment (25-27).
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